(MENAFNEditorial) (EMAILWIRE.COM, October 17, 2013 ) Knoxville, TN Late Tuesday evening the Food and Drug Administration (FDA) posted a notice that a U.S. subsidiary of the German pharmaceutical firm B. Braun Melsungen is recalling some antibiotics after visible particles were found in a sample.
Lot H3A744 of Cefepime for Injection USP and Dextrose Injection USP are being recalled after visible particles such as specs of metal, cotton fiber, and hair were found in a sample.
According to the FDA use of the defective product could result in blood clots leading to stroke, heart attack and other adverse medical events. Patients experiencing health problems should contact their physician and report all issues to the company at 1-800-854-6851.
Although no reports have come forward yet, the drug was distributed to hospitals, pharmacies, and medical suppliers nationwide from February 4th to March 1st of this year.
Although drug recalls are reported frequently the government shutdown has slowed the process down and the FDA has even placed a notice on their website that the information posted may not be up to date.
If you or a loved one has been injured or fallen ill due to a recalled product or Dangerous drug, the victim may be entitled to compensation for medical expenses, pain and suffering, lost wages, and more.
An experienced Knoxville dangerous drug attorney can help you determine what your legal rights are, visit http://www.gregcolemanlaw.com for more information on dangerous prescription drugs.
About Greg Coleman Law
A well-respected name in personal injury law, Greg Coleman Law is committed to helping those who have been injured by the actions of another in the state of Tennessee. The personal injury attorneys at Greg Coleman Law have a wealth of knowledge and experience in premises liability, dangerous drug litigation, medical malpractice, product liability claims, ERISA lawsuits and general class action claims.
Greg Coleman Law
PMP Marketing Group
561-253-6712
pressrelease@pmpmg.com This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php. Source: EmailWire.Com
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.